Abstract:Platelets store a plethora of different molecules within their granules, modulating numerous pathways, not only in coagulation, but also in angiogenesis, wound healing, and inflammatory diseases. These molecules get rapidly released upon activation and therefore represent an easily accessible indirect marker for platelet activation. Accurate analysis of platelet-derived molecules in the plasma requires appropriate anticoagulation to avoid in vitro activation and subsequent degranulation of platelets, potentially causing artificially high levels and masking biologically relevant differences within translational research studies. However, there is still enormous heterogeneity among anticoagulants used to prevent unwanted platelet activation, so that plasma levels reported for platelet granule contents range over several orders of magnitude. To address this problem and to define the most robust method of plasma preparation to avoid in vitro platelet activation during processing, we compared plasma concentrations of the three platelet-stored factors thrombospondin (TSP-1), platelet factor 4 (PF4), and soluble P-selectin (sCD62P) between human blood samples anticoagulated with either citrate-theophylline-adenosine-dipyridamole (CTAD), acid-citrate-dextrose (ACD), citrate, ethylenediaminetetraacetic acid (EDTA) or heparin. Additionally, we assessed the effect of storage temperature and time between blood drawing and sample processing within the differentially anticoagulated samples. Our data strongly support the use of CTAD as anticoagulant for determining plasma concentrations of platelet-stored molecules, as anticoagulation with heparin or EDTA led to a 12.4- or 8.3-fold increase in plasma levels of PF4, respectively. Whereas ACD was similar effective as CTAD, citrate only showed comparable PF4 plasma levels when plasma was kept at 4°C. Moreover, blood sampling with CTAD as anticoagulant resulted in the most reproducible values, even when samples were processed at ambient temperature or after storage over 6 hours. In the latter case, anticoagulation with heparin or EDTA led to artificially high plasma levels indicative of in vitro platelet activation. Therefore, we want to raise scientific awareness for choosing CTAD as optimal anticoagulant for the detection of platelet-stored molecules in plasma.

Fibrinogen present in EDTA--anticoagulated plasma stimulates the tissue-type plasminogen activator-catalysed conversion of plasminogen to plasmin

Fibrinogen present in EDTA— anticoagulated plasma stimulates the tissue-type plasminogen activatorcatalysed conversion of plasminogen to plasmin

The Relationship of Homocysteine Levels to Tissue Plasminogen Activator and Plasminogen Activator Inhibitor in Acute Coronary Syndrome Patients

Fibronectin Exposes Different Domains after Adsorption to a Heparinized and an Unheparinized Poly(vinyl Chloride) Surface.

Novel Distribution Pattern of Fibrinolytic Components in Rabbit Tissues Extract: a Preliminary Study

Interaction of Plasminogen Activators and Plasminogen with Heparin: Effect of Ionic Strength

A comparative study of the promotion of tissue plasminogen activator and pro-urokinase-induced plasminogen activation by fragments D and E-2 of fibrin.

Surface plasmon resonance analysis to evaluate the importance of heparin sulfate groups' binding with human aFGF and bFGF

Optimized plasma preparation is essential to monitor platelet-stored molecules in humans

EDTA stabilizes the concentration of platelet-derived extracellular vesicles during blood collection and handling

Beta2-Glycoprotein I is a Cofactor for Tissue Plasminogen Activator-Mediated Plasminogen Activation.

Lipoprotein(a): a Kinetic Study of Its Influence on Fibrin-Dependent Plasminogen Activation by Prourokinase or Tissue Plasminogen Activator.

Investigation of thrombin concentration at the time of clot formation in simultaneous thrombin and fibrin generation assays

Heparin-Bead Extraction Enhanced Fluorogenic Aptamer-Thrombin Composite Reporter Enables Sensitive and Rapid Detection of Functional Antithrombin

Fibrinogen Adsorption, Platelet Adhesion and Thrombin Generation at Heparinized Surfaces Exposed to Flowing Blood

Fragment E-2 From Fibrin Substantially Enhances Pro-Urokinase-Induced Glu-Plasminogen Activation - A Kinetic-Study Using The Plasmin-Resistant Mutant Prourokinase Ala-158-Rpro-Uk

Anticoagulant function of a 24-Kd fragment isolated from human fibrinogen A alpha chains.

Determination of Human Thrombin-Antithrombin III Complex in Plasma with an Enzyme-Linked Immunosorbent Assay

Bi-cell surface plasmon resonance detection of aptamer mediated thrombin capture in serum

Laboratory Testing for Fibrinogen Disorders: From Routine Investigations to Research Studies